Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/1997
05/13/1997US5629327 Methods and compositions for inhibition of angiogenesis
05/13/1997US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation
05/13/1997US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor
05/09/1997WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
05/09/1997WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
05/09/1997WO1997016435A1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
05/09/1997WO1997016433A1 Protease inhibitors
05/09/1997WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
05/09/1997WO1997016405A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
05/09/1997WO1997016197A1 Extracts of shark cartilage
05/09/1997WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases
05/09/1997CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
05/07/1997EP0771818A2 Biotin derivatives
05/07/1997EP0771815A1 Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof
05/07/1997EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines
05/07/1997EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions
05/07/1997EP0771204A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides
05/07/1997EP0771195A1 Method of inhibiting nitric oxide formation
05/07/1997EP0771191A1 Immunological activity of rhamnolipids
05/07/1997EP0667780A4 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents.
05/07/1997EP0626956B1 Quinolylbenzofuran derivatives as leukotriene antagonists
05/07/1997EP0593575B1 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
05/07/1997CN1149319A Angiostatin and method of use for inhibition of Angiogenesis
05/07/1997CN1149296A Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
05/07/1997CN1149292A Pyrimidinyl derivatives as interleukin inhibitors
05/07/1997CN1149288A Vitamin-D amide derivatives
05/07/1997CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
05/06/1997US5627197 Piperidino- or piperazino-substituted oxazolidinone, thiazolidinones or imidazolidinones
05/06/1997US5627180 Substituted thiosemicarbazonethiones
05/06/1997US5627173 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders
05/03/1997CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
05/02/1997EP0770395A1 Use of botulinum toxins for treating headache
05/02/1997EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition
05/02/1997EP0770137A1 Improvements in production of proteins in host cells
05/02/1997EP0770087A1 Human elastase iv
05/02/1997EP0770081A1 Heterocycle-condensed morphinoid derivatives
05/02/1997EP0770079A1 Heterobicyclic derivatives
05/02/1997EP0770078A1 8-aryl-1,6-naphthyridin-5-ones
05/02/1997EP0770059A1 Substituted benzamidines, their production and their use as medicaments
05/02/1997EP0770058A1 Novel chemical compound, its preparation and use as a drug
05/02/1997EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use
05/02/1997EP0769958A1 Inhibitors of leukocyte adhesion
05/02/1997EP0769947A1 Indolinone compounds for the treatment of disease
05/02/1997EP0769940A1 INDENE sPLA 2? INHIBITORS
05/01/1997WO1997015655A2 New artificial tissue, method for the production and the use thereof
05/01/1997WO1997015592A1 Novel human cysteine protease
05/01/1997WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
05/01/1997WO1997015561A1 Chiral methyl phenyl oxazolidinones
05/01/1997WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
05/01/1997CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
05/01/1997CA2235575A1 Novel human cysteine protease
05/01/1997CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
05/01/1997CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity
04/1997
04/30/1997CN1148505A Activated immune globulin
04/30/1997CN1148503A Application of noval peptidic compound in preparation of medicine
04/30/1997CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders
04/29/1997US5624957 Retinoid active compounds
04/29/1997US5624950 Useful in treatment of analgesia, inflammation, asthma, allergies, central nervous system disorders, cardiovascular disorders, immune system disorders, antispasmodic agents, antiemetic agents
04/29/1997US5624949 Protein kinase C inhibitors
04/29/1997US5624931 Pyrazole derivatives
04/29/1997US5624911 Antiinflammatory agents or analgesics
04/29/1997US5624909 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (e-selectin) and LECAM-1 (l-selectin)
04/28/1997CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
04/24/1997WO1997014716A1 Cyclopeptide derivatives
04/24/1997WO1997014691A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
04/24/1997WO1997014686A1 Pharmaceutically active quinazoline compounds
04/24/1997WO1997014683A2 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
04/24/1997WO1997014671A1 Cyclopentyl tachykinin receptor antagonists
04/24/1997WO1997014432A1 Modulation of integrin-mediated signal transduction
04/24/1997DE19540475A1 Chirale Methylphenyloxazolidinone Chiral methylphenyloxazolidinones
04/24/1997DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives
04/24/1997CA2235304A1 Pharmaceutically active quinazoline compounds
04/24/1997CA2232609A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
04/24/1997CA2207973A1 Modulation of integrin-mediated signal transduction
04/23/1997EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
04/23/1997EP0768888A1 Use of muramyl peptide compounds
04/23/1997EP0768884A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
04/23/1997EP0768883A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
04/23/1997EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds
04/23/1997EP0670825B1 Nitric esters having a pharmacological activity and process for their preparation
04/23/1997EP0623123B1 Benzopyran and related LTB4-antagonists
04/23/1997CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines
04/23/1997CN1148389A Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
04/23/1997CN1148341A Oral liquid alendronate formulations
04/23/1997CN1147948A Traditional Chinese medicinal prepn. for relieving swelling and alleviating pain of throat
04/23/1997CN1147946A Sichuan aconite root analgesic soft extract
04/22/1997US5623057 Pneumococcal polysaccharide conjugate vaccine
04/22/1997US5622990 Dry, roller compacted powder comprising low amount excipients, free of disintegrant
04/22/1997US5622989 Amino-benzofuryl-and thienyl-derivatives
04/22/1997US5622987 Prevent migration or proliferation of smooth muscle cells
04/22/1997US5622984 Amidinophenol derivatives
04/22/1997US5622982 Enzyme inhibitors; antiinflammatory agents
04/22/1997US5622948 Pyrrole pyridazine and pyridazinone anti-inflammatory agents
04/22/1997US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability
04/22/1997US5622721 Dosage forms of risedronate
04/22/1997US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin
04/17/1997WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods
04/17/1997WO1997013755A1 1,3,5-trisubstituted pyrazoles for treament of inflammation
04/17/1997WO1997013751A1 Indole carbamates as leukotriene antagonists
04/17/1997WO1997013514A1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy